PMI Reports Strong 2022 Results and 2023 Goals

Feb.09.2023
PMI Reports Strong 2022 Results and 2023 Goals
Philip Morris International discusses Q4 & full-year 2022 results and 2023 goals with a focus on NGP and HTU products.

Philip Morris International Inc. (NYSE:PM) held a webcast on the morning of February 9, 2023 Eastern Time (February 9, 2023 at 10:00 PM Beijing Time) to present its financial results for the fourth quarter and full year 2022.


In a recent PMI radio broadcast, CEO Jacek Olczak and CFO Emmanuel Babeau discussed PMI's performance in 2022 and outlook for 2023, while also addressing questions from investors and journalists. 2FIRSTS provided full coverage of the meeting and summarized the key points as follows:


Annual Key Market Data | Source: PMI


The next generation product (NGP) has received a lot of attention.


In 2022, Phillip Morris International acquired major players in the oral nicotine industry, Swiss Match, and released their next generation heated tobacco product, Iluma, with over 20 million IQOS users worldwide. The next generation of products shows strong momentum. The report lasted approximately 40 minutes, with over half of the time dedicated to discussing the market revenue of PMI's NGP products. PMI expressed their main goal for 2023 is to accelerate the achievement of a smoke-free world.


Main Goals for 2023 | Source: PMI


In their report, PMI noted that they will continue to promote their NGP (Next Generation Products) business in order to gradually replace traditional cigarettes and convert smokers. This will be supplemented by their non-combustible products such as Swiss Match and ZYN, which offer nicotine orally. The ultimate goal is to create a "smoke-free world". The company also mentioned their global partnership with Korean tobacco giant KT&G on the HTU (Heat-Not-Burn Tobacco Units) technology.


Philip Morris International (PMI) has reportedly predicted that the company will face significant challenges in the first quarter of 2023 due to the combined effects of rising costs of combustible tobacco and the turnover of IQOS users. However, PMI still remains optimistic about its forecast for 2023 and believes that its HTU department profits will benefit from the increased costs of combustible tobacco. This confidence is mainly derived from PMI's productivity and pricing power in the HTU sector.


The cost of combustible tobacco is rising, while HnB is expected to contribute significantly. Source: 2FIRSTS.


Annual performance report.


PMI's total revenue for the full year 2022 reached $31.8 billion (approximately RMB 216.2 billion), a year-on-year increase of 1.1%.


The net revenues from smoke-free products account for 32.1% of the total net revenues, or 31.3% if Russia and Ukraine are excluded. Following the acquisition of Swedish Match, PMI defines "smoke-free products" as all Swedish Match products (excluding combustible tobacco products), PMI's heating non-burning products (HnB), electronic vaping products, oral nicotine products, and health and wellness products.


In the IQOS market, the market share of heated tobacco products has increased by 1.1 percentage points, reaching 8.0%, or by 1.4 percentage points, reaching 7.9%, excluding Russia and Ukraine.


Market share of heated tobacco products increasing year by year | Source: PMI - Regular quarterly dividends increased by 1.6% to reach $1.27 per share, or $5.08 per share on an annualized basis.


The net income from smokeless products accounts for 36.0% of the total net income, or 35.6% if excluding Russia and Ukraine.


HTU's market share in the IQOS market increased by 1.4 percentage points to reach 8.5%, and without including Russia and Ukraine, it increased by 1.8 percentage points to 8.5%.


As of the end of this quarter, the estimated total number of IQOS users is around 24.9 million, of which approximately 17.8 million have switched to using IQOS and have stopped smoking (excluding Russia and Ukraine, the figures are around 20.3 million and 14.2 million respectively).


The number of users has surpassed 20 million with steady conversion rates, according to PMI.


CEO speech


Jacek Olczak stated that despite the challenges posed by the Ukrainian conflict, supply chain pressures, and global inflation, the business environment in 2022 will be challenging. However, driven by the continued growth of IQOS and strong performance in the combustible tobacco category, the company achieved very strong overall adjusted performance for the year.


Jacek Olczak, CEO of PMI, stated that the company is making progress in becoming a mostly smoke-free company, with smoke-free products generating nearly one-third of total net revenue this year. PMI has achieved two important milestones in its smoke-free transformation for 2022, including the acquisition of Sweden Match and an agreement to fully control IQOS in the US by April 2024. The company is prepared to accelerate its smoke-free journey.


By 2023, we aim to become the global leader in smokeless products with our two leading brands, IQOS and ZYN, along with continued innovation in our wider range of smokeless offerings. Despite inflationary pressure and transitional effects related to the deployment of ILUMA, we forecast organic top-line growth of 7% to 8.5% and diluted earnings per share growth of 7% to 9% on a currency-neutral basis this year.


It is expected that Swedish Match, under the leadership of ZYN in the United States, will continue to experience strong business growth in 2023. PMHH (the Dutch holding company of PMI) is currently the owner of 94.81% of the company's shares.


Question and answer segment.


Financial giants including JPMorgan and Morgan Stanley, as well as media and industry professionals, participated in the Q&A session.


A spokesperson for Morgan Stanley asked about PMI's plans for the US market, to which Jacek replied that PMI intends to go public with Iluma in the US before 2024, and will promote Swiss Match's oral nicotine products nationwide. He also added that PMI currently relies heavily on cigar sales for revenue in the US market.


When asked about the EU's ban on flavored heated tobacco, Jacek stated that the ban may have some similarities to the ban on cigarette flavors and menthol a few years ago. "To be honest, the ban on cigarette flavors did not have a substantial impact on cigarette sales, so let's wait and see.


To obtain further details, please refer to the full annual report. 2FIRSTS will continue to monitor this topic, so stay tuned.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives